We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maxcyte Inc | LSE:MXCT | London | Ordinary Share | COM STK USD0.01 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 335.00 | 330.00 | 340.00 | 335.00 | 330.00 | 335.00 | 658 | 08:00:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 41.29M | -37.92M | -0.3664 | -11.84 | 346.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/10/2021 23:45 | If the Allogene issue promotes a move away from ‘off the shelf’ treatments to treatments using the patients own cells, it may be a good thing for Maxcyte in the long term? | davep4 | |
08/10/2021 16:17 | edward - this is a decent short summary: Nothing any investor here shouldn't already know.... | supernumerary | |
08/10/2021 16:17 | looks like panic over in the States | lancasterbomber | |
08/10/2021 14:29 | Messing around with cells at the bleeding edge of biotech can have unforeseen adverse affects? | trident5 | |
08/10/2021 14:26 | can anyone explain in plain english what the problem is from a scientific point of view? | edwardt | |
08/10/2021 12:04 | hxxps://www.fiercebi | hj996 | |
08/10/2021 11:22 | Time to top up? | advfnsta | |
08/10/2021 10:21 | No read across the other partnerships. The trial pause is specific to Allogene. | hj996 | |
08/10/2021 09:48 | That’s the $100b question! | trickydicky1 | |
08/10/2021 09:04 | Is this stumble confined to the Allogene therapy or does it have read across to the other partnerships? | trident5 | |
07/10/2021 22:40 | Bad news. Looks like we’re in for a rough Friday. After hrs tumble For ref; | shstt1 | |
07/10/2021 22:37 | Both Allogene and Maxcyte recovering, somewhat..... | assagai | |
07/10/2021 21:02 | Bad news! Mxct down heavily after hours in US | nimbo1 | |
06/10/2021 14:50 | fca should do something about it but it is a open secret price gauging that the platforms get away with. disgusting. | edwardt | |
06/10/2021 11:20 | Yes. And that's why, if you hold shares in an ISA, in overseas companies - each trade is converted back to GBP and then back to the overseas currency. Sell Microsoft and buy Apple in an ISA and your Microsoft proceeds convert to GBP and then back to USD to buy Apple. It's a blatant rip off. | trident5 | |
06/10/2021 11:12 | aj bell are being greedy - look at their fx rates as a reason for this. | edwardt | |
06/10/2021 10:12 | I have accounts with AJ Bell and iDealing. Lucky for me my MXCT are held with iDealing and no problems dealing with them online. | spittingbarrel | |
05/10/2021 15:15 | So much for the narrative that the yanks are happy to pay more for shares in these companies. | trident5 | |
05/10/2021 13:52 | And they're all busy selling, too. | trident5 | |
05/10/2021 13:18 | From what I can see, last 3 month average volumes: - US: 669k shares - AIM: 155k shares So there's certainly more volume being traded in the US and more than 4:1 ratio. It always felt like the AIM-listing was likely to be axed at some point and if this ratio becomes more one-sided, I think it will be brought forward | adamb1978 | |
05/10/2021 12:36 | IG Markets trade in the London line and I believe have been quite active on it | rgmgo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions